Correlation Between Phoenix Biotech and Enterprise

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Phoenix Biotech and Enterprise at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phoenix Biotech and Enterprise into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phoenix Biotech Acquisition and Enterprise 40 Technology, you can compare the effects of market volatilities on Phoenix Biotech and Enterprise and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phoenix Biotech with a short position of Enterprise. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phoenix Biotech and Enterprise.

Diversification Opportunities for Phoenix Biotech and Enterprise

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Phoenix and Enterprise is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Phoenix Biotech Acquisition and Enterprise 40 Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enterprise 40 Technology and Phoenix Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phoenix Biotech Acquisition are associated (or correlated) with Enterprise. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enterprise 40 Technology has no effect on the direction of Phoenix Biotech i.e., Phoenix Biotech and Enterprise go up and down completely randomly.

Pair Corralation between Phoenix Biotech and Enterprise

If you would invest  1,073  in Enterprise 40 Technology on September 4, 2024 and sell it today you would earn a total of  0.00  from holding Enterprise 40 Technology or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Phoenix Biotech Acquisition  vs.  Enterprise 40 Technology

 Performance 
       Timeline  
Phoenix Biotech Acqu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Phoenix Biotech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Phoenix Biotech is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Enterprise 40 Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enterprise 40 Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Enterprise is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Phoenix Biotech and Enterprise Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Phoenix Biotech and Enterprise

The main advantage of trading using opposite Phoenix Biotech and Enterprise positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phoenix Biotech position performs unexpectedly, Enterprise can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enterprise will offset losses from the drop in Enterprise's long position.
The idea behind Phoenix Biotech Acquisition and Enterprise 40 Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fundamental Analysis
View fundamental data based on most recent published financial statements